uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results

uniQure N.V. (NASDAQ:QURE) is one of the 12 Best Performing Stocks in the Last 3 Months. On October 8, RBC Capital reiterated a Buy rating on uniQure N.V. (NASDAQ:QURE) and increased its price target from $55 to $65. Moreover, on October 6, H.C. Wainwright also raised its price target on uniQure N.V. (NASDAQ:QURE) from $70 to $110 and kept a Buy rating. uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results These updates came after the company reported positive topline data from it ...